Literature DB >> 34799989

Non-incisional pleurectomy/decortication for malignant mesothelioma after cardiac surgery.

Kentaro Miura1, Kimihiro Shimizu1, Seiki Hasegawa2, Sachie Koike1, Shunichiro Matsuoka1, Tetsu Takeda1, Takashi Eguchi1, Kazutoshi Hamanaka1, Momoko Takizawa3.   

Abstract

A 70-year-old man diagnosed with right-sided malignant epithelial pleural mesothelioma, underwent pleurectomy/decortication after three courses of neoadjuvant chemotherapy. He had a history of mitral valve replacement and maze procedure with median sternotomy, and the procedures resulted in strong adhesion from the apex to the mediastinal side. In particular, the peeling of the area where the tumor invaded the pericardium required the most attention; however, the involved pericardium could be partially resected without damaging the right atrium. Finally, en bloc macroscopic complete resection with the entire pleura was successfully performed without conversion to extrapleural pneumonectomy.
© 2021 The Authors. Thoracic Cancer published by China Lung Oncology Group and John Wiley & Sons Australia, Ltd.

Entities:  

Keywords:  cardiac surgery; malignant epithelial pleural mesothelioma; pleurectomy/decortication

Mesh:

Year:  2021        PMID: 34799989      PMCID: PMC8720616          DOI: 10.1111/1759-7714.14231

Source DB:  PubMed          Journal:  Thorac Cancer        ISSN: 1759-7706            Impact factor:   3.500


INTRODUCTION

Malignant pleural mesothelioma (MPM) is an extremely aggressive malignant tumor with poor prognosis. Multimodal therapies including surgery, chemotherapy, and radiotherapy have been adopted, and the purpose of surgery is to achieve complete macroscopic resection. Some reports have referred to curative surgical procedures. Recently, a lung‐sparing surgical technique is acceptable, and the superiority of pleurectomy/decortication (P/D) compared to extrapleural pneumonectomy (EPP) has been reported. However, the degree of surgical difficulty varies depending on the tumor invasion and adhesion during P/D, and sometimes shifts to EPP are necessary. We report the first case of a patient who underwent successful P/D for MPM with a history of cardiac surgery using median sternotomy.

CASE REPORT

A 70‐year‐old man underwent mitral valve replacement and a maze procedure for atrial fibrillation with median sternotomy 2 years, previously. The follow‐up chest X‐ray scan showed a gradual increase in right pleural effusion, and he was referred to our hospital. Chest computed tomography (CT) revealed right pleural effusion and pleural thickening (Figure 1(a)). He underwent right pleural biopsy by video‐assisted thoracic surgery (VATS) and was diagnosed with epithelial malignant pleural mesothelioma. A positron emission tomography (PET) CT showed no lymph node or distant metastases, and the stage of MPM was c‐T3N0M0 Stage IB according to the International Association for the Study of Lung Cancer (IASLC) 8th edition.
FIGURE 1

Chest computed tomography (CT) and positron emission tomography (PET)‐CT of the patient. (a) Right pleural effusion and pleural thickening on initial examination. (b) Chest CT after neoadjuvant chemotherapy. The tumor (2 × 2 cm) was in contact with the right atrium (arrow), and invasion was not ruled out. (c) PET‐CT after neoadjuvant chemotherapy showed no lymph node or distant metastases, and the patient was diagnosed with stable disease (SD)

Chest computed tomography (CT) and positron emission tomography (PET)‐CT of the patient. (a) Right pleural effusion and pleural thickening on initial examination. (b) Chest CT after neoadjuvant chemotherapy. The tumor (2 × 2 cm) was in contact with the right atrium (arrow), and invasion was not ruled out. (c) PET‐CT after neoadjuvant chemotherapy showed no lymph node or distant metastases, and the patient was diagnosed with stable disease (SD) The patient received three courses of cisplatin plus pemetrexed neo‐adjuvant chemotherapy. The chest CT after the chemotherapy showed a tumor measuring 2 × 2 cm, making contact with the right atrium, and invasion could not be ruled out (Figure 1(b)). The PET‐CT showed no lymph node or distant metastases, and the patient was diagnosed with stable disease (SD) (Figure 1(c)). He underwent P/D as a curative surgery. Strong adhesions on the mediastinal side were considered because of the previous cardiac surgery via median sternotomy. An extracorporeal circulation was placed on standby in preparation for massive bleeding, especially in case of right atrial rupture. As advocated by Hasegawa et al. we performed the P/D technique without any pleural incision (“non‐incisional P/D"), to achieve en bloc removal of the entire pleura. First, a posterolateral incision was made, and we performed a P/D seventh costal bed thoracotomy. Second, extrapleural dissection was initiated using the fingers. There was strong adhesion from the apex to the mediastinal side, especially to the back of the sternum because of the previous cardiac surgery, and careful peeling was required (Figure 2(a)). The chest CT confirmed that the tumor was in contact with the pericardium and direct invasion to the pericardium was suspected (Figure 2(b)). The pericardium was opened carefully. The pericardium and right atrium were strongly adherent; however, there was no direct invasion (Figure 2(c)). There was no pericardial effusion, and polypropylene thread (Prolene, Ethicon) from the past cardiac surgery could be observed (Figure 2(d)). The peeling proceeded gradually, and finally, the involved pericardium was partially resected without damaging the right atrium. Peeling of the visceral pleura was then performed. Finally, en bloc macroscopic complete resection of the entire pleura was performed.
FIGURE 2

Surgical findings. (a) There was strong adhesion from the apex to the mediastinal side due to the previous cardiac surgery. (b),(c) Shows the tumor invasion to the pericardium. The pericardium was carefully opened; however, the pericardium and right atrium were strongly adherent. (d) Proline from the past cardiac surgery could be observed

Surgical findings. (a) There was strong adhesion from the apex to the mediastinal side due to the previous cardiac surgery. (b),(c) Shows the tumor invasion to the pericardium. The pericardium was carefully opened; however, the pericardium and right atrium were strongly adherent. (d) Proline from the past cardiac surgery could be observed The total blood loss was 5300 mL, and the operation time was 688 minutes. The air leak stopped 3 days after the surgery, and he was discharged 17 days after the surgery.

DISCUSSION

To our knowledge, this is the first case report of a patient with MPM who underwent successful P/D after cardiac surgery with median sternotomy. The highlights of this surgery are as follows: (1) the adhesion from the apex to the mediastinal side was strong, particularly at the back of the sternum; however, peeling was possible and en bloc macroscopic complete resection with the entire pleura could be completed without conversion to EPP; and (2) it is possible to peel off the tumor in contact with the pericardium and right atrium. Formation of intrapericardial adhesions after median sternotomy is a widely known phenomenon. In this case, strong intrapericardial and mediastinal adhesions were anticipated, especially on the right side, because the patient had undergone a maze procedure in addition to mitral valve replacement via median sternotomy. The conversion to EPP might be considered if peeling of the pleura was impossible. Reports on the superiority of P/D, including low morbidity and mortality in terms of preservation of pulmonary function, have been increasing in recent years. , , It was noteworthy that the P/D was successfully completed without conversion to EPP. Here, the preoperative chest CT scan revealed that the tumor contacts the right atrium and invasion to the pericardium or right atrium could not be ruled out. If the right atrium had ruptured during the peeling, there was possibility of massive bleeding; therefore, an extracorporeal circulation was put on standby. Fortunately, adhesion between the pericardium and right atrium was detachable, and there was no direct invasion of the tumor into the right atrium. We recommend sufficient preparation for emergent bleeding, such as having an artificial heart‐lung machine on standby when operating on similar cases. In summary, the following scenarios may have occurred in this case: (1) the massive bleeding by rupture of right atrium; and (2) the conversion to the EPP. As a countermeasure, extracorporeal circulation was put on standby. We had confirmed that conversion from P/D to EPP might be possible in the point of preoperative respiratory function and cardiac function. Fortunately, these scenarios had not occurred in this case; however, it is important to be well prepared for each scenario. In conclusion, we successfully treated a patient with MPM who underwent P/D after cardiac surgery with median sternotomy. Although the adhesions from the apex to the mediastinum and pericardium were strong, en bloc resection could be completed without conversion to EPP by careful peeling.

CONFLICTS OF INTEREST

The authors declare no conflicts of interest.
  9 in total

1.  The role of surgical cytoreduction in the treatment of malignant pleural mesothelioma: meeting summary of the International Mesothelioma Interest Group Congress, September 11-14, 2012, Boston, Mass.

Authors:  Valerie Rusch; Elizabeth H Baldini; Raphael Bueno; Marc De Perrot; Raja Flores; Seiki Hasegawa; Walter Klepetko; Lee Krug; Loïc Lang-Lazdunski; Harvey Pass; Walter Weder; David J Sugarbaker
Journal:  J Thorac Cardiovasc Surg       Date:  2013-02-14       Impact factor: 5.209

2.  Non-incisional pleurectomy/decortication.

Authors:  Seiki Hasegawa; Masaki Hashimoto; Nobuyuki Kondo; Yoshihiro Miyamoto
Journal:  Eur J Cardiothorac Surg       Date:  2020-07-01       Impact factor: 4.191

3.  Surgical Risk and Survival Associated With Less Invasive Surgery for Malignant Pleural Mesothelioma.

Authors:  Seiki Hasegawa; Nobuyuki Kondo; Seiji Matsumoto; Teruhisa Takuwa; Masaki Hashimoto; Ayumi Kuroda; Toru Nakamichi; Norihiko Kamikonya; Tohru Tsujimura; Takashi Nakano
Journal:  Semin Thorac Cardiovasc Surg       Date:  2019-01-10

4.  Prevention of postoperative pericardial adhesions with a novel regenerative collagen sheet.

Authors:  Hiroyuki Tsukihara; Shinichi Takamoto; Kazuo Kitahori; Kazuhisa Matsuda; Arata Murakami; Richard J Novick; Yoshihiro Suematsu
Journal:  Ann Thorac Surg       Date:  2006-02       Impact factor: 4.330

5.  Prolonged post-recurrence survival following pleurectomy/decortication for malignant pleural mesothelioma.

Authors:  Yuichiro Kai; Yasuhiro Tsutani; Norifumi Tsubokawa; Masaoki Ito; Takeshi Mimura; Yoshihiro Miyata; Morihito Okada
Journal:  Oncol Lett       Date:  2019-01-28       Impact factor: 2.967

6.  Initial analysis of the international association for the study of lung cancer mesothelioma database.

Authors:  Valerie W Rusch; Dorothy Giroux; Catherine Kennedy; Enrico Ruffini; Ayten K Cangir; David Rice; Harvey Pass; Hisao Asamura; David Waller; John Edwards; Walter Weder; Hans Hoffmann; Jan P van Meerbeeck
Journal:  J Thorac Oncol       Date:  2012-11       Impact factor: 15.609

7.  Clinical Outcomes With Recurrence After Pleurectomy/Decortication for Malignant Pleural Mesothelioma.

Authors:  Akifumi Nakamura; Teruhisa Takuwa; Masaki Hashimoto; Ayumi Kuroda; Toru Nakamichi; Seiji Matsumoto; Nobuyuki Kondo; Takashi Kijima; Koichiro Yamakado; Seiki Hasegawa
Journal:  Ann Thorac Surg       Date:  2020-01-18       Impact factor: 4.330

8.  Non-incisional pleurectomy/decortication for malignant mesothelioma after cardiac surgery.

Authors:  Kentaro Miura; Kimihiro Shimizu; Seiki Hasegawa; Sachie Koike; Shunichiro Matsuoka; Tetsu Takeda; Takashi Eguchi; Kazutoshi Hamanaka; Momoko Takizawa
Journal:  Thorac Cancer       Date:  2021-11-20       Impact factor: 3.500

9.  Phase II trial of neoadjuvant pemetrexed plus cisplatin followed by surgery and radiation in the treatment of pleural mesothelioma.

Authors:  Rea Federico; Favaretto Adolfo; Marulli Giuseppe; Spaggiari Lorenzo; DePas Tommaso Martino; Ceribelli Anna; Paccagnella Adriano; Crivellari Gino; Russo Francesca; Ceccarelli Matteo; Kazeem Gbenga; Marchi Paolo; Facciolo Francesco
Journal:  BMC Cancer       Date:  2013-01-16       Impact factor: 4.430

  9 in total
  1 in total

1.  Non-incisional pleurectomy/decortication for malignant mesothelioma after cardiac surgery.

Authors:  Kentaro Miura; Kimihiro Shimizu; Seiki Hasegawa; Sachie Koike; Shunichiro Matsuoka; Tetsu Takeda; Takashi Eguchi; Kazutoshi Hamanaka; Momoko Takizawa
Journal:  Thorac Cancer       Date:  2021-11-20       Impact factor: 3.500

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.